202 related articles for article (PubMed ID: 16634362)
1. Atherogenesis in rheumatology.
van Leuven SI; Kastelein JJ; D'Cruz DP; Hughes GR; Stroes ES
Lupus; 2006; 15(3):117-21. PubMed ID: 16634362
[TBL] [Abstract][Full Text] [Related]
2. Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study.
Vlachoyiannopoulos PG; Kanellopoulos PG; Ioannidis JP; Tektonidou MG; Mastorakou I; Moutsopoulos HM
Rheumatology (Oxford); 2003 May; 42(5):645-51. PubMed ID: 12709540
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular events in systemic lupus erythematosus and rheumatoid arthritis : emerging concepts, early diagnosis and management.
Chogle AR; Chakravarty A
J Assoc Physicians India; 2007 Jan; 55():32-40. PubMed ID: 17444342
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors.
Zeller CB; Appenzeller S
Curr Cardiol Rev; 2008 May; 4(2):116-22. PubMed ID: 19936286
[TBL] [Abstract][Full Text] [Related]
5. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
6. Systemic lupus erythematosus and cardiovascular disease.
Frostegård J
Lupus; 2008 May; 17(5):364-7. PubMed ID: 18490408
[TBL] [Abstract][Full Text] [Related]
7. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
Salmon JE; Roman MJ
Am J Med; 2008 Oct; 121(10 Suppl 1):S3-8. PubMed ID: 18926167
[TBL] [Abstract][Full Text] [Related]
8. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
[TBL] [Abstract][Full Text] [Related]
9. Traditional and nontraditional risk factors for atherosclerosis in patients with systemic lupus erythematosus.
Pompilian V; Badea C; Dragomanu I; Bălăşescu E; Tănăsescu C
Rom J Intern Med; 2008; 46(3):195-8. PubMed ID: 19366077
[TBL] [Abstract][Full Text] [Related]
10. Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.
Tektonidou MG; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Protogerou A
Autoimmun Rev; 2017 Mar; 16(3):308-312. PubMed ID: 28147263
[TBL] [Abstract][Full Text] [Related]
11. Annexin A5 in cardiovascular disease and systemic lupus erythematosus.
Cederholm A; Frostegård J
Immunobiology; 2005; 210(10):761-8. PubMed ID: 16325495
[TBL] [Abstract][Full Text] [Related]
12. Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders.
Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Luque-Tévar M; Torres-Granados C; Aguirre-Zamorano MA; Collantes-Estevez E; Pérez-Sánchez C
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188016
[TBL] [Abstract][Full Text] [Related]
13. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques.
Bolla E; Tentolouris N; Sfikakis PP; Tektonidou MG
Front Immunol; 2022; 13():1077166. PubMed ID: 36700208
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus.
Kahlenberg JM; Kaplan MJ
Annu Rev Med; 2013; 64():249-63. PubMed ID: 23020882
[TBL] [Abstract][Full Text] [Related]
16. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
Narshi CB; Giles IP; Rahman A
Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of atherosclerosis and cardiovascular disease in antiphospholipid syndrome and systemic lupus erythematosus. New therapeutic approaches.
Lopez-Pedrera C; Aguirre-Zamorano MÁ; Pérez-Sánchez C
Med Clin (Barc); 2017 Aug; 149(4):160-169. PubMed ID: 28619369
[TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
Sarzi-Puttini P; Atzeni F; Carrabba M
Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammation as a risk factor for atherothrombosis.
van Leuven SI; Franssen R; Kastelein JJ; Levi M; Stroes ES; Tak PP
Rheumatology (Oxford); 2008 Jan; 47(1):3-7. PubMed ID: 17702769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
